Showing results (171-180 of 188) with videos related to
Sort By:
Pageof 19
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 27, 2023
Personalized neoantigen-based T cell therapy triggers cytotoxic lymphocytes expressing polyclonal TCR against metastatic ovarian cancerShuen-Iu Hung, Mu-Tzu Chu, Ming-Mo Hou, et al.Journal of the Formosan Medical Association = Taiwan Yi Zhi|September 7, 2024
Comprehensive genomic profiling in multiple cancer types: A comparative analysis of the National Biobank Consortium of Taiwan and clinical practice cohortsLing-Jen Hung, Chen-Yang Huang, Kai-Che Tung, et al.Chang Gung Medical Journal|November 7, 2012
Everolimus in metastatic renal cell carcinoma: preliminary experience from Chang Gung Memorial HospitalWen-Kuan Huang, Chuang-Chi Liaw, See-Tong Pang, et al.BMC Cancer|October 22, 2020
The association between immune-related adverse events and survival outcomes in Asian patients with advanced melanoma receiving anti-PD-1 antibodiesChiao-En Wu, Chan-Keng Yang, Meng-Ting Peng, et al.Journal of Cancer|December 1, 2025
Validation of WHO 2017 Classification and Identification of Prognostic Factors in Patients with Pancreatic Neuroendocrine Neoplasms: A Real-World Experience in TaiwanWei-Pang Ho, Wen-Chi Chou, Chia-Hsun Hsieh, et al.JAMA Network Open|February 3, 2021
Comparison Between Non-vitamin K Antagonist Oral Anticoagulants and Low-Molecular-Weight Heparin in Asian Individuals With Cancer-Associated Venous ThromboembolismDong-Yi Chen, Chi-Nan Tseng, Ming-Jer Hsieh, et al.The Ocular Surface|October 29, 2025
Ocular manifestations in Stevens‒Johnson syndrome/toxic epidermal necrolysis in cancer patientsJin-Jhe Wang, Chun-Bing Chen, Eugene Yu-Chuan Kang, et al.Lung Cancer (Amsterdam, Netherlands)|February 29, 2008
Increased epidermal growth factor receptor (EGFR) gene copy number is strongly associated with EGFR mutations and adenocarcinoma in non-small cell lung cancers: a chromogenic in situ hybridization study of 182 patientsJohn Wen-Cheng Chang, Hui-Ping Liu, Meng-Heng Hsieh, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 1, 2026
Patient-Reported Outcomes with Consolidation Durvalumab Versus Placebo Following Concurrent Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer: Results from the Phase 3 ADRIATIC TrialSilvia Novello, Ying Cheng, David Spigel, et al.Proceedings of the National Academy of Sciences of the United States of America|December 21, 2007
MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinibJames Bean, Cameron Brennan, Jin-Yuan Shih, et al.Pageof 19